Medical Research News

Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.

Avail Clinical Research Announces Gastroesophageal Reflux Disease Research Studies in DeLand, FL

Avail Clinical Research Announces Gastroesophageal Reflux Disease Paid Research Studies & Paid Clinical Trials in DeLand, Orlando & Daytona Beach, Florida - February 26, 2010 - Avail Clinical Research

Avail Clinical Research Announces Fibromyalgia Research Studies in DeLand, FL

Avail Clinical Research announces the launch of several research studies to test investigational treatment options for those already diagnosed with fibromyalgia. - February 24, 2010 - Avail Clinical Research

Speed New Drug and Medical Device Time to Market with Advice in New Book by Cerulean's Managing Director

Speed New Drug and Medical Device Time to Market with Advice in New Book by Cerulean's Managing Director

FDA compliance guru, John Avellanet, shows biopharmaceutical and device executives how to speed time to market with new medicines and turn regulatory compliance into a competitive business advantage in his new book, Get to Market Now! Turn FDA Compliance into a Competitive Edge in the Era of Personalized Medicine. - February 19, 2010 - Cerulean Associates LLC

Avail Clinical Research Announces Diabetes Paid Research Studies & Paid Clinical Trials in DeLand, Orlando & Daytona Beach, Florida

Avail Clinical Research, a privately owned research facility, founded in 1998 in DeLand, FL, announces the launch of several research studies to test investigational treatment options for those already diagnosed with diabetes. “We are very pleased to begin the systemic evaluation of our... - February 17, 2010 - Avail Clinical Research

SNUS and Tobacco Research Study; Avail Clinical Research

Avail Clinical Research, announced the beginning of a clinical research study for people who regularly consume tobacco products such as: SNUS, snuff, chewing tobacco, dip, and other oral tobaccos. - February 07, 2010 - Avail Clinical Research

Lupus Research Institute Invites Scientists with Innovative Ideas to Help Pioneer Lupus Discovery

The world’s leading private supporter of innovative research in systemic lupus erythematosus (lupus)—the Lupus Research Institute (LRI)—invites scientists with bold new approaches to discovering the cause, improving treatment, and curing lupus to apply for financial support. - February 05, 2010 - Lupus Research Institute

International Medical Association Publishes Guidelines for Tracking Safety of Adult Stem Cell Procedures

International medical association publishes landmark best practices guidelines that define the methodology for tracking patient safety and outcomes after stem cell treatments. - February 05, 2010 - International Cellular Medicine Society

Noesys Data Adds Seasoned Industry Veteran to Bolster Sales

Noesys Data announced today that Thomas Bennett, a 15 year veteran in physiological data collection and analysis market, has joined its team to deliver its unique solutions to the scientific research community. - February 03, 2010 - Noesys Data

Biomarker Discovery Grant Deadline Extended

Biomarker Discovery Grant Deadline Extended

RayBiotech, Inc., today announced that they are extending the deadline for submitting applications for its Biomarker Discovery Pilot Grant program. RayBiotech will now accept applications for the pilot grants through February 22nd, 2010. “The last-minute surge in interest in the grant program has been overwhelming,” said Brett Burkholder, Director of Marketing & Business Development for RayBiotech, Inc. - February 02, 2010 - RayBiotech, Inc

Avail Clinical Research Announces Irritable Bowel Syndrome Research Studies in DeLand, FL

Irritable Bowel Syndrome research studies for those already diagnosed with IBS being conducted in DeLand, FL. - January 27, 2010 - Avail Clinical Research

AncestrybyDNA Reveals Secrets of Past Heritage

DNA Diagnostics Centre UK has launched AncestrybyDNA™, a unique DNA test that reveals a person's ancestral origins. - January 26, 2010 - DNA Diagnostics Centre

Researchers Study Gene Critical in Animal Development

Biomedical researchers at the NC State University College of Veterinary Medicine using fluorescent zebrafish embryos to study gene responsible for animal growth, cancer formation. - January 24, 2010 - North Carolina State Univeristy College of Veterinary Medicine

Flexfit Announces Successful 2009 Sponsorship of Mauli Ola Foundation’s Surf Experience Days to Benefit Kids with Cystic Fibrosis

Flexfit Announces Successful 2009 Sponsorship of Mauli Ola Foundation’s Surf Experience Days to Benefit Kids with Cystic Fibrosis

Flexfit is grateful to Mauli Ola Foundation for the opportunity to have sponsored their 2009 Surf Experience Days, which helped spread awareness of Cystic Fibrosis. - January 11, 2010 - Flexfit

Researchers Develop First Successful Hair Cloning Technique - A Major Advancement in Hair Restoration

Gary Hitzig, M.D., a New York hair transplant surgeon and researcher and Jerry Cooley, M.D., a Charlotte dermatologist and researcher, are the first medical doctors to successfully develop a hair cloning technique using an FDA-cleared wound healing powder. - January 08, 2010 - Gary Hitzig, M.D.

Two Long-Established Independent IRBs Discussing Merger

Two Independent Review Boards, responsible for the review of human subject research are discussing a merger to utilize their combined 46 years of experience to create a new Limited Liability Corporation. - January 07, 2010 - Ethical and Independent Review Services

Founder of Macular Degeneration Foundation Dies at 94

Founder of Macular Degeneration Foundation Dies at 94

After dedicating his life to public awareness of ARMD (Age-Related Macular Degeneration, Edmund J. Aleksandrovich (Ed Aleks) dies at the age of 94. - December 22, 2009 - Macular Degeneration Foundation

Medical Society Announces Publication of Largest Stem Cell Safety Study to Date

The ICMS announces the publication of the largest stem cell safety study. Using the guidelines put forward by the ICMS, 227 patients were followed for complications after receiving adult stem cell therapies using a novel new protocol. No serious complications were reported. - December 19, 2009 - International Cellular Medicine Society

Unbound Medicine and Wiley-Blackwell Announce Partnership with Launch of Evidence Central™

Unbound Medicine and Wiley-Blackwell Announce Partnership with Launch of Evidence Central™

Unbound Medicine, a leader in knowledge management solutions for healthcare, today announced the launch of Evidence Central™, an integrated, evidence-based solution, with content from its partner, Wiley-Blackwell, the scientific, technical, medical, and scholarly publishing business of John... - December 15, 2009 - Unbound Medicine

Insights with Host Hugh Downs Creates New Series on Epilepsy

Epilepsy subject targeted as programming for medical documentaries. - December 11, 2009 - InsightsSeries

ALPCO Diagnostics and BioPorto Diagnostics Enter Into Distribution Partnership

ALPCO Diagnostics and BioPorto Diagnostics Enter Into Distribution Partnership

ALPCO Diagnostics has taken on the responsibility to promote and sell BioPorto Diagnostics’ immunoassays on the US and Canadian markets. The primary product focus is BioPorto’s unrivalled portfolio of human and animal immunoassays for measuring NGAL – the breakthrough kidney... - December 08, 2009 - ALPCO

D.I.S.S. Announces Rocky Mountain Laboratories Selects ITS for NHP Telemetry Based Biodefense and Infectious Disease Research

Rocky Mountain Laboratories (RML) in Hamilton, MT, part of the NIAID, has chosen ITS (Integrated Telemetry Systems) as the supplier for non-human primate (NHP) telemetry hardware and data collection and analysis software to operate in its BSL-4 primate telemetry facilities. This makes the RML the... - December 05, 2009 - D.I.S.S., LLC

Human Placenta: a Cure for Football Injuries?

Journal of Wound Care (JWC) has published a paper on the use of human aqueous placental extract to treat wounds (“Human aqueous placental extract as a wound healer” Vol. 18, Iss. 11, 06 Nov 2009, pp 462 – 46). This paper is particularly relevant in light of the media attention... - December 03, 2009 - Journal of Wound Care

Expert Panel Issues Final Consensus Statement on Skin Changes at Life’s End (SCALE)

Panel determines that current understanding of this complex phenomenon is limited and that additional research is necessary - December 02, 2009 - Gaymar Industries

KLIXAR Joins Health Decisions’ Global Network of CROs Advocating Higher Efficiency Standards

Latin American CRO is now a certified partner in Health Decisions’ Agile Clinical Network, dedicated to improving processes and systems across global trials - November 20, 2009 - Health Decisions

Hamner Institutes Scientist to Speak at Conference Focusing on Military Life Sciences Initiatives

The Hamner Institutes for Health Sciences has announced that Melvin Andersen, Ph.D., director of The Hamner Program in Chemical Safety Sciences and director of the Computational Biology Division, will join a panel at the U.S. Department of Defense’s Transformational Medical Technologies... - November 19, 2009 - The Hamner Institutes for Health Sciences

News at MEDICA: ALPCO Announces the Launch of Several New Products in 2009

ALPCO will return to MEDICA, showcasing these new immunoassay kits, which cement the company's perennial committment to serving the demands of the pre-clinical research market. This will be ALPCO's fourth year at MEDICA as part of the “Best of New England” consortium of companies, located in the US pavilion in Halle 3, D15-4. - November 16, 2009 - ALPCO

CuraBase to be Presented at  the AACR-NCI-EORTC Molecular Targets and Cancer Therpeutics Conference in Boston

CuraBase to be Presented at the AACR-NCI-EORTC Molecular Targets and Cancer Therpeutics Conference in Boston

Targeted Therapeutics Consulting, Inc. announced today that its lead product, the cancer drug development database CuraBase®, will be introduced to the scientific community at the AACR-NCI-EORTC Molecular Targets and Cancer Therpeutics Conference in Boston on Monday, November 16. Dr. W. Michael... - November 14, 2009 - Targeted Therapeutics Consulting, Inc.

Symbyos Announces Its ToothIQ Dental Videos Are Now Available for Dentist Websites

Symbyos Announces Its ToothIQ Dental Videos Are Now Available for Dentist Websites

Symbyos, the developers of ToothIQ have released their dental animations to dentists for use on their own practice websites via ToothIQPro. - November 11, 2009 - Symbyos

Dr. Ann A. Kiessling, Director of the Bedford Stem Cell Research Foundation Honored with the Jacob Heskel Gabbay Award for Biotechnology and Medicine

Dr. Ann A. Kiessling, Director of the Bedford Stem Cell Research Foundation Honored with the Jacob Heskel Gabbay Award for Biotechnology and Medicine

101 healthy babies have been born from SPAR, the Special Program of Assisted Reproduction, which allows HIV positive men to safely father children. Dr. Kiessling’s recent work is bridging the gap between assisted reproduction and stem cell science. - November 09, 2009 - Bedford Stem Cell Research Foundation

ENCO Pharmaceutical Development Announces Selection of LabWare as Its LIMS Provider

ENCO Pharmaceutical Development, Inc. acquires a state-of-the-art LabWare laboratory information management system for its faciities. - October 30, 2009 - Enco Pharmaceutical Development, Inc.

XTractor Premium Scales a New Milestone as It Surpasses 300,000 Mark of Expert Annotated PubMed Facts

Premium platform surpasses 302,269 "Expert" annotated facts from PubMed. XTractor is also available as LinkOut service of Entrez gene that allows to link XTractor directly from Entrez databases to a wide range of information and services beyond the Entrez system. - October 25, 2009 - Molecular Connections Pvt. Ltd.

Moms on a Mission: Will Moms of America be the Champions of Change?

Two moms, from opposite ends of the country, who have yet to meet, answer the call to action with an astounding "yes." - October 19, 2009 - Brad Kaminsky Foundation for Brain Tumor Research

Health Decisions Builds a Network of International CROs Trained in High-Efficiency Adaptive Research

Adaptive CRO invites like-minded research organizations from around the world to get certified in Agile Clinical Development - October 18, 2009 - Health Decisions

LCH Clinical Research, LLC to Host Wine and Cheese Networking Event

LCH Clinical Research, LLC, an Atlanta-based research company announces its networking event Lynn Harding, CEO of LCH Clinical Research has over 15 years of experience in clinical research. She is a key leader in a movement to make LCH Clinical Research the premiere destination for clinical... - October 16, 2009 - LCH Clinical Research, LLC

ALPCO Introduces Immundiagnostik Bone Sialoprotein (BSP) ELISA to North America

ALPCO Introduces Immundiagnostik Bone Sialoprotein (BSP) ELISA to North America

ALPCO Diagnostics introduces Immundiagnostik's Bone Sialoprotein ELISA to North America. The BSP ELISA exhibits outstanding sensitivity and specificity for the underglycosylated or carbohydrate deficient Bone Sialoprotein. - October 15, 2009 - ALPCO

The Hamner Institutes For Health Sciences Launches Twitter Page

The Hamner Institutes for Health Sciences has announced the official launch of its Twitter page (www.twitter.com/thehamner). The nonprofit research organization will use the account to report news and happenings, engage the scientific and local communities, and share research on chemical and drug... - October 15, 2009 - The Hamner Institutes for Health Sciences

Study: the New Buzz on Detecting Tinnitus

A Henry Ford Hospital study finds that a non-invasive imaging technique can aid in the diagnosis of tinnitus, a perceived ringing of the head and ears, offering hope to the more than 50 million patients with tinnitus. This imaging technique can determine the site of perception of tinnitus in the brain, which could in turn allow physicians to target the area with electrical or chemical therapies to lessen symptoms. - October 07, 2009 - Henry Ford Health System

ALPCO and Athera Biotechnologies Sign Distribution Agreement in North America

ALPCO and Athera Biotechnologies Sign Distribution Agreement in North America

ALPCO Diagnostics, a leading developer and distributor of high quality immunoassay kits, is pleased to announce that they have signed with Athera Biotechnologies as their new distribution channel in the North America. Sean Conley, COO of ALPCO, said “We are very excited about the... - October 06, 2009 - ALPCO

New HD360˚ Module Gives Clinical Trial Monitors Greater Control While Reducing Costs

Health Decisions integrates Monitor View into its HD360˚ clinical trial management system. - September 27, 2009 - Health Decisions

RayBiotech to Award Biomarker Discovery Grants

RayBiotech, Inc., today announced today the establishment of its Biomarker Discovery Pilot Grant program, consisting of restricted grants of $10,000 to $20,000 worth of RayBiotech products and services to conduct their proposed biomarker research, which would potentially be sufficient to generate preliminary data for additional grant funding. - September 26, 2009 - RayBiotech, Inc

MarketsandMarkets: Global Biosimilars Product Market Worth $19.4 Billion by 2014

The biosimilars market is highly fragmented and its huge opportunities are attracting new players. Favourable regulatory developments in the biosimilars sector are expected to increase the market share and profit margins while reducing medical expenditure. - September 25, 2009 - marketsandmarkets

MedSource Hires New Associate Director of Clinical Operations

MedSource, a Contract Research Organization (CRO) providing Phase I-IV clinical trials support, announced today that Ms. Parisa Jabbarzadegan has joined its company as Associate Director of Clinical Operations. With more than 12 years of experience in the clinical research industry she brings a... - September 25, 2009 - MedSource

Cerno Bioscience’s MassWorksTM Has Proven to be 99% Accurate Software for the Identification of Unknown Compounds

MassWorks employs Cerno’s patented calibration technology to equip unit mass resolution mass spectrometers with up to 100 times more mass accuracy and unparallel Spectral Accuracy through exact isotope modeling. Through MassWorks, customers can utilize unit mass resolution mass spectrometers to identify the formulas of unknown compounds. This function, before MassWorks, was usually reserved for more expensive high resolution mass spectrometers. - September 22, 2009 - Cerno Bioscience

Block Imaging Announces Acquisition and New Subsidiary Company

Block Imaging Announces Acquisition and New Subsidiary Company

Block Imaging International, Inc., the premier global provider of Pre-owned and Refurbished Medical Imaging Systems, Parts, and Services, announced today its acquisition of Benchmark Radiology LLC., headquartered near Ft. Wayne, IN. Block Imaging also announced today the establishment of a new... - September 17, 2009 - Block Imaging

Lupus Research Institute National Coalition Goes to Washington

Lupus Research Institute National Coalition Goes to Washington

LRI Advocacy Day on the Hill Promotes Health Care Concerns of Lupus Patients. - September 17, 2009 - Lupus Research Institute

DZS Software’s Clinical Trial Management Software (CTMS) Selected by PhotoThera, Inc., a Carlsbad, California Medical Device Manufacturer

ClinPlus® web-based (CTMS) proves to be best choice for proprietary device technology using transcranial laser therapy (TLT) for the treatment of acute ischemic stroke and other neurological diseases and disorders. - September 16, 2009 - DZS Software Solutions

Center for Autism and Related Disorders' Study Finds Chewing Gum an Effective Treatment for Rumination in Children with Autism

CARD research team discovers chewing gum to be a practical and effective treatment to prevent rumination in children with autism. The complete study is published in the Summer 2009 Edition of the Journal of Applied Behavior Analysis. - September 10, 2009 - Center for Autism and Related Disorders

Outsourced Paralegal Services LLC Asserts Link Between Chapter 7 & 13 Bankruptcy Filings and Medical Bills

Outsourced Paralegal Services LLC Asserts Link Between Chapter 7 & 13 Bankruptcy Filings and Medical Bills

Consumer bankruptcy freelance paralegal company Outsourced Paralegal Services, LLC examines connection between chronic illness and consumer bankruptcy filings. - September 03, 2009 - Outsourced Paralegal Services

Founding Members of Initiatives Healthcare Bring Unprecedented Leadership to Florence Arizona Hospital, Tri-Valley Region

Edward McEachern, MD, CEO and Brent Cherne, CPA, CFO, combine talents to bring experience and leadership to the new hospital being constructed in Florence Arizona. Florence Community Healthcare will open its doors in late Fall 2009. - September 03, 2009 - Florence Community Healthcare

Lupus Research Institute Encouraged by Phase 2 Trial Results of Experimental Drug Epratuzumab

The Lupus Research Institute (LRI) and its National Coalition of state and local organizations congratulate Immunomedics and UCB on the successful results of the Phase 2b clinical trial of epratuzumab for people with systemic lupus. “It is heartening to see success in lupus trials and to see... - September 03, 2009 - Lupus Research Institute

Press Releases 1,451 - 1,500 of 1,631